George Karpouzas MD FACR
Lupus & Related, Myositis, Rheumatoid Arthritis & Related, Spondyloarthropathy
Professor, David Geffen School of Medicine, UCLA Chief, Division of Rheumatology, Harbor-UCLA
Join to view full profile
1000 W Carson StreetE4-17.Torrance, CA 90509
Phone+1 310-222-3697
Fax+1 310-782-0595
Dr. Karpouzas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2000 - 2003
University of California (San Diego) Medical CenterFellowship, Rheumatology, 1998 - 2000
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1995 - 1998
Aristotle University of Thessaloniki School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1997 - 2027
FL State Medical License 2016 - 2018
American Board of Internal Medicine Rheumatology
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Rheumatology
Awards, Honors, & Recognition
- Meyer Award Arthritis Foundation, Southern California Chapter, 2003
- Solomon Scholars Research Award For outstanding original research David Geffen School of Medicine, at UCLA, 2002
- Fellow American College of Rheumatology, 1999
Clinical Trials
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
- Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis Start of enrollment: 2025 Jan 01
- The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) Start of enrollment: 2022 Mar 31
Roles: Principal Investigator
Publications & Presentations
PubMed
- Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthri...George A Karpouzas, Miguel A Gonzalez-Gay, Virginia Pascual-Ramos, Durga Prasanna Misra, Elena Myasoedova
RMD Open. 2026-06-24 - Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis.George A Karpouzas, Frederik Cosedis Enevoldsen, Panteha Rezaeian, Dzenan Masic, Matthew J Budoff
Rheumatology. 2026-05-05 - Pericoronary fat attenuation and its association with atherosclerosis in rheumatoid arthritis compared with controls: a cross-sectional study.George A Karpouzas, Frederik Cosedis Enevoldsen, Panteha Rezaeian, Dzenan Masic, Matthew J Budoff
RMD Open. 2026-03-24
Journal Articles
- Highly sensitive cardiac troponin-I predicts occult coronary plaque burden, composition and cardiovascular events in patients with rheumatoid arthritisKarpouzas GA, Estis J, Rezaeian P, Todd J, Budoff MJ, Rheumatology (Oxford), 1/1/2018
- ReplyGrossman JM, McMahon MA, Fitzgerald JD, Karpouzas GA, Chen W, Hahn BH, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Arthritis Care Res (Hoboken), 1/1/2012
- Shortness of Breath and Hemoptysis in a 35-Year-Old Man with Extensive Perihilar InfiltratesJung C, Stringer W, Karpouzas GA, Chest, 1/1/2005
Books/Book Chapters
Abstracts/Posters
- Predictors of Change in Coronary Plaque Burden and Composition in Patients with Rheumatoid ArthritisKarpouzas G, Ormseth S, Hernandez E, Budoff M, Arthritis Rheumatol, 1/1/2018
- Implications of Coronary Artery Calcium Score and Its Change over Time As Markers of Coronary Plaque Vulnerability and Patient Risk in Rheumatoid ArthritisKarpouzas G, Ormseth S, Hernandez E, Budoff M, Arthritis Rheumatol, 1/1/2018
- Impact of Inflammation and Biologic Treatments on Generation and Progression to Advanced Calcified Coronary Plaques in Rheumatoid ArthritisKarpouzas G, Ormseth S, Hernandez E, Budoff M, Arthritis Rheumatol, 1/1/2018
Lectures
- Clinical Manifestations of Rapid Disease Progression in Moderate to Severe Rheumatoid ArthritisMultiple Locations, 2017, 2018 - 1/1/2018
- Accelerated coronary Atherogenesis and cardiovascular risk stratification in Rheumatoid Arthritis,UCLA Medical Center, Westwood, CA, 2014, 2018; Harbor-UCLA Medical Center, Torrance, CA, 2017 - 1/1/2018
- A New Treatment Option for Adult Patients with Moderately to Severely Actively Rheumatoid ArthritisMultiple Locations, 2017, 2018 - 1/1/2018
Other
- Rheumatology circles: Role of Golimumab in the treatment of moderate to severe Rheumatoid arthritisKarpouzas GA, Janssen National Faculty series National WebEx
1/1/2012 - Thesis: ANCA vasculitis in GreeceKarpouzas GA
National and Kapodistrian University of Athens, School of Medicine, Zografou, Greece - 1/1/1995
Press Mentions
Estrogen Levels Mediate Atherosclerosis Risk in RA According to Sex, Menopause StatusOctober 29th, 2025- Study: Increased Heart Risk Isn't a Given in Rheumatoid ArthritisApril 10th, 2025
- Effect of BMI on Cardiovascular Risk in Rheumatoid Arthritis Varies by Antibody Status and Biologic UseApril 9th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
